The first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle, US health officials said on Monday
“The open-label trial will enrol 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks,” the US National Institutes of Health (NIH) said in a statement.
ALSO READ: Coronavirus vaccine starts clinical trial in US today
“The first participant received the investigational vaccine today.”
(Straitstimes)
Afrobeats sensation Davido and American R&B star Chris Brown are gearing up for a massive…
•Someone called my son an imbecile on X –Bovi Africa’s first-ever talk concert, WithChude Live,…
Every family in Nigeria has been advised to ensure they have an engineer, particularly a…
"We remain unwavering in our commitment to policies that promote employee welfare, workplace safety, and…
Nigerian National Petroleum Corporation (NNPC) Foundation has conducted a free eye cataract surgery programme for…
The girl-child advocate further called on private companies and non-governmental organisations to create more opportunities…
This website uses cookies.